Last updated at 08 Mar 2024 12:00 PM
Director
DIN: 08667852
Janice Vijay Gandhi is currently associated with 4 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at JENESIS PHARMA TRADING LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08667852.Janice Vijay Gandhi is currently involved in 3 different roles. Their most recent position is with ONCOCELL ORGANICS LLP as a Designated Partner. The first company Janice Vijay Gandhi was appointed to as a director was JENESIS PHARMA TRADING LLP. Janice Vijay Gandhi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Janice Vijay Gandhi is currently associated with 4 companies in various capacities such as Designated Partner, Director and Individual Promoter. They serve as a Director at JENESIS PHARMA TRADING LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08667852.Janice Vijay Gandhi is currently involved in 3 different roles. Their most recent position is with ONCOCELL ORGANICS LLP as a Designated Partner. The first company Janice Vijay Gandhi was appointed to as a director was JENESIS PHARMA TRADING LLP. Janice Vijay Gandhi is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
6
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (2)
Past Companies (0)
1y 3m 8 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| VJ BIO FARMA PRIVATE LIMITED | Director | 07-Jun-2022 |
| VJ BIO FARMA PRIVATE LIMITED | Individual Promoter | 07-Jun-2022 |
| ADDIS HEALTHCARE PRIVATE LIMITED | Director | 25-Jul-2022 |
| ADDIS HEALTHCARE PRIVATE LIMITED | Individual Promoter | 25-Jul-2022 |